Praziquantel EP Impurity A

Praziquantel EP Impurity A is a structurally related degradation byproduct of praziquantel, characterized by the loss of the 4-hydroxyl group and formation of a 4-pyrimidinone ring system. This impurity retains the core 2-cyclohexylpyrimidine scaffold but exhibits a ketone functionality at the C4 position, distinguishing it from the parent compound's hydroxyl substitution. The compound arises via thermal or oxidative degradation pathways during praziquantel synthesis or storage. It serves as a critical reference standard for HPLC-based impurity profiling in pharmaceutical quality control.